Several specialized organizations worldwide focus on the synthesis of complex drug APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone Acetate. These compounds present significant hurdles in process development due to their molecular complexity. The producers of these APIs often employ specialized processes and adhere to strict quality